Anika Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Anika Therapeutics (ANIK) Tops Q1 EPS by 12c; $50M Buyback
May 2, 2019 4:43 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.31, $0.12 better than the analyst estimate of $0.19. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $21.88 million.
Announces $50 Million Share Repurchase Program.
Anika is off to a strong start in 2019, with double-digit... More
